IFNA2 Protein
-
- Target See all IFNA2 Proteins
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Protein Type
- Recombinant
- Biological Activity
- Active
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Application
- Functional Studies (Func), Antibody Production (AbP), Standard (STD), Protein Interaction (PI)
- Specificity
- Optimal preservation of protein structure, post-translational modifications and functions.
- Characteristics
-
- Recombinant human IFNA2 / Interferon alpha-2 protein expressed in E. coli.
- Produced with end-sequenced ORF clone
- Tested for bioactivity.
- Purity
- > 95 % , as determined by Coomassie stained SDS-PAGE.
- Endotoxin Level
- Less than 0.01 ng per μg protein as determined by the LAL method.
- Biological Activity Comment
- Specific activity is 1.86 x 108 units/mg, determined in a cytopathic effect inhibition assay using EMC virus on A549 cells.
- Top Product
- Discover our top product IFNA2 Protein
-
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays
Protein-protein interaction
In vitro biochemical assays and cell-based functional assays - Restrictions
- For Research Use only
-
- Concentration
- > 50 μg/mL
- Buffer
- 1 x PBS, pH 7.3
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Alternative Name
- Ifna2,interferon alpha-2 (IFNA2 Products)
- Synonyms
- IFN-alphaA Protein, IFNA Protein, IFNA2B Protein, INFA2 Protein, Ifa2 Protein, IFNA2 Protein, interferon alpha 2 Protein, interferon, alpha 2 Protein, interferon-alpha-2 Protein, interferon alpha-2 Protein, IFNA2 Protein, Ifna2 Protein, ifna2 Protein, IFN-ALPHA2 Protein, LOC102142148 Protein
- Background
- Produced by macrophages, IFN-alpha have antiviral activities. [UniProtKB/Swiss-Prot Function]
- Molecular Weight
- 19.4 kDa
- NCBI Accession
- NP_000596
- Pathways
- JAK-STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-